Wyeth loratadine deal
This article was originally published in The Tan Sheet
Executive Summary
Impax Labs to supply Wyeth Consumer Healthcare with generic OTC forms of Schering-Plough's Claritin-D 12-hour, 24-hour extended release tablets, Hayward, Calif.-based firm reports June 20. "Semi-exclusive" worldwide agreement allows Impax to license products to companies other than Wyeth, demands up-front milestone payments. Deal appears to cover loratadine forms other than those sought in Wyeth's 505(b)(2) application submitted to FDA early this year (1"The Tan Sheet" Feb. 4, 2002, p. 3)...
|
Impax Labs to supply Wyeth Consumer Healthcare with generic OTC forms of Schering-Plough's Claritin-D 12-hour, 24-hour extended release tablets, Hayward, Calif.-based firm reports June 20. "Semi-exclusive" worldwide agreement allows Impax to license products to companies other than Wyeth, demands up-front milestone payments. Deal appears to cover loratadine forms other than those sought in Wyeth's 505(b)(2) application submitted to FDA early this year (1 (Also see "Claritin Patent Infringement Suit Brings Industry Into OTC Antihistamine Fray" - Pink Sheet, 4 Feb, 2002.), p. 3).... |